Подписаться
Daniel  Von Hoff
Daniel Von Hoff
Chief Scientific Officer US Oncology, Chief Scientific Officer TGen, Distinguished Professor Mayo
Подтвержден адрес электронной почты в домене tgen.org
Название
Процитировано
Процитировано
Год
Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial
HA Burris, MJ Moore, J Andersen, MR Green, ML Rothenberg, ...
Journal of clinical oncology 15 (6), 2403-2413, 1997
74401997
Increased survival in pancreatic cancer with nab-paclitaxel plus gemcitabine
DD Von Hoff, T Ervin, FP Arena, EG Chiorean, J Infante, M Moore, T Seay, ...
New England Journal of Medicine 369 (18), 1691-1703, 2013
65572013
Risk factors for doxorubicin-lnduced congestive heart failure
DD Von Hoff, MW Layard, P Basa, HL DAVIS Jr, AL Von Hoff, ...
Annals of internal medicine 91 (5), 710-717, 1979
31031979
Enzymatic targeting of the stroma ablates physical barriers to treatment of pancreatic ductal adenocarcinoma
PP Provenzano, C Cuevas, AE Chang, VK Goel, DD Von Hoff, ...
Cancer cell 21 (3), 418-429, 2012
20772012
Hypersensitivity reactions from taxol.
RB Weiss, RC Donehower, PH Wiernik, T Ohnuma, RJ Gralla, DL Trump, ...
Journal of clinical oncology 8 (7), 1263-1268, 1990
15351990
Inhibition of the hedgehog pathway in advanced basal-cell carcinoma
DD Von Hoff, PM LoRusso, CM Rudin, JC Reddy, RL Yauch, R Tibes, ...
New England Journal of Medicine 361 (12), 1164-1172, 2009
13382009
Phase I and pharmacologic study of OSI-774, an epidermal growth factor receptor tyrosine kinase inhibitor, in patients with advanced solid malignancies
M Hidalgo, LL Siu, J Nemunaitis, J Rizzo, LA Hammond, C Takimoto, ...
Journal of clinical oncology 19 (13), 3267-3279, 2001
12562001
Gemcitabine plus nab-paclitaxel is an active regimen in patients with advanced pancreatic cancer: a phase I/II trial
DD Von Hoff, RK Ramanathan, MJ Borad, DA Laheru, LS Smith, TE Wood, ...
Journal of Clinical Oncology 29 (34), 4548, 2011
12272011
ONYX-015, an E1B gene-attenuated adenovirus, causes tumor-specific cytolysis and antitumoral efficacy that can be augmented by standard chemotherapeutic agents
C Heise, A Sampson-Johannes, A Williams, F Mccormick, DD Von Hoff, ...
Nature medicine 3 (6), 639-645, 1997
12241997
Treatment of medulloblastoma with hedgehog pathway inhibitor GDC-0449
CM Rudin, CL Hann, J Laterra, RL Yauch, CA Callahan, L Fu, T Holcomb, ...
New England Journal of Medicine 361 (12), 1173-1178, 2009
11962009
Preclinical development and clinical translation of a PSMA-targeted docetaxel nanoparticle with a differentiated pharmacological profile
J Hrkach, D Von Hoff, MM Ali, E Andrianova, J Auer, T Campbell, ...
Science translational medicine 4 (128), 128ra39-128ra39, 2012
11932012
Nanoliposomal irinotecan with fluorouracil and folinic acid in metastatic pancreatic cancer after previous gemcitabine-based therapy (NAPOLI-1): a global, randomised, open …
A Wang-Gillam, CP Li, G Bodoky, A Dean, YS Shan, G Jameson, ...
The Lancet 387 (10018), 545-557, 2016
11462016
Quantitative analysis of MDR1 (multidrug resistance) gene expression in human tumors by polymerase chain reaction.
KE Noonan, C Beck, TA Holzmayer, JE Chin, JS Wunder, IL Andrulis, ...
Proceedings of the National Academy of Sciences 87 (18), 7160-7164, 1990
10651990
Phase III trial of gemcitabine plus tipifarnib compared with gemcitabine plus placebo in advanced pancreatic cancer
E Van Cutsem, H Van De Velde, P Karasek, H Oettle, WL Vervenne, ...
Journal of clinical oncology 22 (8), 1430-1438, 2004
9902004
Tumor-stroma interactions in pancreatic ductal adenocarcinoma
D Mahadevan, DD Von Hoff
Molecular cancer therapeutics 6 (4), 1186-1197, 2007
7372007
A phase II trial of gemcitabine in patients with 5-FU-refractory pancreas cancer
ML Rothenberg, MJ Moore, MC Cripps, JS Andersen, RK Portenoy, ...
Annals of Oncology 7 (4), 347-353, 1996
7361996
Toxic effects of cis-dichlorodiammineplatinum (II) in man.
DD Von Hoff, R Schilsky, CM Reichert, RL Reddick, M Rozencweig, ...
Cancer treatment reports 63 (9-10), 1527-1531, 1979
7221979
American Society of Clinical Oncology 2008 clinical practice guideline update: use of chemotherapy and radiation therapy protectants
ML Hensley, KL Hagerty, T Kewalramani, DM Green, NJ Meropol, ...
Journal of clinical oncology 27 (1), 127-145, 2009
6852009
nab-Paclitaxel Plus Gemcitabine for Metastatic Pancreatic Cancer: Long-Term Survival From a Phase III Trial
D Goldstein, RH El-Maraghi, P Hammel, V Heinemann, V Kunzmann, ...
Journal of the National Cancer Institute 107 (2), dju413, 2015
6842015
Ras protein farnesyltransferase: a strategic target for anticancer therapeutic development
EK Rowinsky, JJ Windle, DD Von Hoff
Journal of Clinical Oncology 17 (11), 3631-3652, 1999
6831999
В данный момент система не может выполнить эту операцию. Повторите попытку позднее.
Статьи 1–20